KPV Peptide: Anti-Inflammatory Research

Introduction

KPV is a tripeptide (Lys-Pro-Val) derived from alpha-MSH (melanocyte-stimulating hormone). It is studied for its anti-inflammatory properties in preclinical research models. KPV is a component of the KLOW Blend, which is sourced from a leading peptide supplier UK and combines it with GHK-Cu, TB-500, and BPC-157, ensuring researchers can buy peptides UK that meet rigorous standards.

Mechanism of Action

KPV is a C-terminal fragment of alpha-MSH. While alpha-MSH acts through melanocortin receptors, KPV is studied for anti-inflammatory effects that may be mediated through both receptor-dependent and receptor-independent mechanisms.

In research models, KPV is associated with:

• Modulation of inflammatory signalling pathways
• Effects on immune cell function
• Anti-inflammatory activity in intestinal and skin models

Research Applications

KPV is studied in:

• Anti-inflammatory research — modulation of inflammatory pathways in preclinical models
• Intestinal inflammation — studied in models of gastrointestinal inflammation
• Skin inflammation — studied in dermatological inflammation models
• Combined regeneration research — as part of the KLOW Blend, KPV adds an anti-inflammatory axis to collagen synthesis, angiogenesis, and cell migration

KPV in the KLOW Blend

The KLOW Blend uses the best reviewed peptides to ensure consistency, and combines:

• 50mg GHK-Cu (collagen synthesis)
• 10mg TB-500 (cell migration)
• 10mg BPC-157 (angiogenesis)
• 10mg KPV (anti-inflammatory)

This four-compound blend allows researchers to study the combined effects of regeneration and inflammation modulation — the full repair and recovery cascade, featuring the highest purity peptides.

Research Use Only

KPV and all blends are for laboratory research use only. Not for human consumption, medical diagnosis, or treatment.